Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 381

Similar articles for PubMed (Select 22691291)

1.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.

Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876.

2.

Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis.

Ciurzyński M, Bienias P, Lichodziejewska B, Kurnicka K, Szewczyk A, Glińska-Wielochowska M, Kurzyna M, Błaszczyk M, Liszewska-Pfejfer D, Pruszczyk P.

Clin Rheumatol. 2008 Aug;27(8):991-7. doi: 10.1007/s10067-008-0837-9. Epub 2008 Feb 7.

PMID:
18256871
3.

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2013;15(6):R193.

4.

Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.

Mathai SC, Bueso M, Hummers LK, Boyce D, Lechtzin N, Le Pavec J, Campo A, Champion HC, Housten T, Forfia PR, Zaiman AL, Wigley FM, Girgis RE, Hassoun PM.

Eur Respir J. 2010 Jan;35(1):95-104. doi: 10.1183/09031936.00074309. Epub 2009 Jul 30.

5.
6.

Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.

Miller L, Chartrand S, Koenig M, Goulet JR, Rich É, Chin AS, Chartrand-Lefebvre C, Abrahamowicz M, Senécal JL, Grodzicky T.

Scand J Rheumatol. 2014;43(4):314-23. doi: 10.3109/03009742.2013.854407. Epub 2014 Feb 6.

PMID:
25089008
7.

Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.

Cavagna L, Caporali R, Klersy C, Ghio S, Albertini R, Scelsi L, Moratti R, Bonino C, Montecucco C.

J Rheumatol. 2010 Oct;37(10):2064-70. doi: 10.3899/jrheum.090997. Epub 2010 Jul 15.

PMID:
20634241
8.

High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.

Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.

Arthritis Rheum. 2008 Jan;58(1):284-91. doi: 10.1002/art.23187.

9.

Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension.

Dimitroulas T, Giannakoulas G, Karvounis H, Sfetsios T, Koliakos G, Parcharidis G, Settas L.

Int J Cardiol. 2007 Sep 14;121(1):135-7. Epub 2006 Nov 7.

PMID:
17088004
10.

The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.

Choi HJ, Shin YK, Lee HJ, Kee JY, Shin DW, Lee EY, Lee YJ, Lee EB, Song YW.

Clin Rheumatol. 2008 Apr;27(4):437-42. Epub 2007 Sep 25.

PMID:
17899307
11.

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.

Eur Heart J. 2006 Jun;27(12):1485-94. Epub 2006 Apr 27.

12.

Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension.

Mukerjee D, Yap LB, Holmes AM, Nair D, Ayrton P, Black CM, Coghlan JG.

Respir Med. 2003 Nov;97(11):1230-6.

PMID:
14635979
13.

N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH.

Simeoni S, Lippi G, Puccetti A, Montagnana M, Tinazzi E, Prati D, Corrocher R, Lunardi C.

Rheumatol Int. 2008 May;28(7):657-60. Epub 2007 Dec 19.

PMID:
18092166
14.

Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.

Dimitroulas T, Giannakoulas G, Papadopoulou K, Sfetsios T, Karvounis H, Dimitroula H, Parcharidou D, Koliakos G, Garyfallos A, Styliadis I, Settas L.

Clin Rheumatol. 2010 Sep;29(9):957-64. doi: 10.1007/s10067-010-1494-3. Epub 2010 Jun 5.

PMID:
20526641
15.

Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.

Ciurzyński M, Bienias P, Irzyk K, Kostrubiec M, Bartoszewicz Z, Siwicka M, Stelmaszczyk-Emmel A, Górska E, Demkow U, Pruszczyk P.

Clin Rheumatol. 2014 Jan;33(1):83-9. doi: 10.1007/s10067-013-2354-8. Epub 2013 Aug 14.

16.

N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?

Allanore Y, Wahbi K, Borderie D, Weber S, Kahan A, Meune C.

Ann Rheum Dis. 2009 Dec;68(12):1885-9. doi: 10.1136/ard.2008.098087. Epub 2008 Dec 3.

PMID:
19054819
17.

NT-proBNP levels in systemic sclerosis: association with clinical and laboratory abnormalities.

Oravec RM, Bredemeier M, Laurino CC, Pinotti AF, Rohde LE, Brenol JC, Xavier RM.

Clin Biochem. 2010 Jun;43(9):745-9. doi: 10.1016/j.clinbiochem.2010.03.011. Epub 2010 Mar 27.

PMID:
20350538
18.

Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.

Gladue H, Altorok N, Townsend W, McLaughlin V, Khanna D.

Semin Arthritis Rheum. 2014 Feb;43(4):536-41. doi: 10.1016/j.semarthrit.2013.08.002. Epub 2013 Sep 5. Review.

19.

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M.

Chest. 2006 May;129(5):1313-21.

PMID:
16685024
20.

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.

Coghlan JG, Denton CP, Grünig E, Bonderman D, Distler O, Khanna D, Müller-Ladner U, Pope JE, Vonk MC, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg DM, McLaughlin VV, Seibold JR; DETECT study group.

Ann Rheum Dis. 2014 Jul;73(7):1340-9. doi: 10.1136/annrheumdis-2013-203301. Epub 2013 May 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk